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IN RECENT YEARS immunological
methods have been applied to elucidating
the structure and molecular biology of
chromatin, and quantifying carcinogen
adducts formed in DNA. Such studies
have increased the limits of detection pre-
viously available and have opened up new
avenues for the study of the distribution
of adducts in chromatin and within cel-
lular subpopulations. These achievements
have accrued from the application of
sensitive immunoassays, using polyclonal
and now, with increasing importance,
monoclonal antibodies. These methods
were the subject of a recent International
Workshop held at the Paterson Labora-
tories.
Single-stranded nucleicacids andnucleo-
sides modified by carcinogenic agents,
when conjugated either electrostatically
or covalently with carrier proteins such
as bovine serum albumin or haemocyanin,
are able to elicit an antibody response.
Such conjugates have been used to pro-
duce both polyclonal and monoclonal
antibodies specific for DNA damage by
both physical and chemical agents. Many
antibodies have now been characterized
and used to quantify carcinogen-DNA
adducts, by radioimmunoassay (RIA),
enzyme-linked immunosorbent assav
(ELISA), ultrasensitive enzyme radio-
immune assay (USERIA) or its fluoro-
metric equivalent, using 4-methylumbel-
liferyl phosphate.
Antibodies were described that are
specific for thymine glycol produced in
DNA irradiated with ionizing radiation or
UV (Erlanger), for thymine dimers which
are the major UV photoproduct in DNA
(Strickland) and for DNA exposed to UV'
radiation in the presence of 8-methoxy-
psoralen (Zarebska). The exquisite speci-
ficity possible with antibodies was well
demonstrated by monoclonal antibodies
specific for 06-alkyldeoxyguanosines, 02_
alkyldeoxythymidines and 04-alkylde-
oxythymidines (Saffhill, Rajewsky) and
by the best polyclonal antibodies produced
in rabbits, which were of comparable
affinity and specificity (Van der Laken).
These antibodies show > 107-fold less
reactivity with uinmodified nucleosides
than with the specific alkylating deoxy-
nucleoside. The primary site ofrecognition
is alkylation at the appropriate 0-atom
and methyl, ethyl and butyl groups are
distinguished. Polyclonal and monoclonal
antibodies recognizing DNA modified by
aflatoxin B1 (AFBI) (Haugen, Hertzog),
2-acetylaminofluorene (AAF) (Poirier,
Leng, Van der Laken, Baan), benz(a)-
pyrenediolepoxide (BPDE-I) (Slor) and
styrene oxide (Legraverend) were also
described. Antibodies against AFB1 itself
are able to measure AFBI metabolites in
urine (Sizaret).
The sensitivity of the immunoassays is
of 0- -00 fmol, and their usefulness has
been demonstrated by the measurement
of adducts formed in DNA with biologic-
ally meaningfuil doses. In several casesINTERNATIONAL WORKSHOP ON IMMIUNE ASSAY OF NUCLEAR ANTIGENS
validation of the immunoassay has been
made by demonstrating good statistical
agreement with an independent parallel
assessment of adduct formation in DNA
from cells or tissues exposed to radio-
labelled agent.
The reaction with carcinogens is not
uniformly distributed along the DNA,
aind nucleosomal-core proteins may influ-
ence the reactivity of N-acetoxy-AAF
with internucleosomal DNA (Bases).
Spacer proteins covalently bound to 3'
and 5' ends of DNA are believed to form
staggered protein discontinuities in DNA
that are resistant to alkali and proteases
(Werner). Antibodies that recognize these
spacers also bind to filaments in the cyto-
plasm that are not composed of tubulin
or actin. Evidence was presented that
alkylation adducts may be more prevalent
in regions close to the spacers. Reaction of
AAF or chlorodiethyl triamine platinum-
II chloride with G-C rich DNA-like poly-
mers produces a transition from B-form
DNA to Z-form DNA, whilst this power
transition is prevented by binding cis-
diammine dichloroplatinum II (cis-platin
(Leng). Antibodies specific for Z-DNA
were described, which bind to polytene
chromosomes of Drosophila, then identi-
fying the natural occurrence of Z-DNA,
though whether this occurs in polytene
bands or interbands in different species
remains controversial.
The structure of chromatin has been
probed using antibodies to DNA and
chromosomal proteins. Micro-injection of
affinity-purified antibodies against HMG
and histone proteins into the cytoplasm
and nucleus of cells, reveals the distribu-
tion of specific antigens and permits the
investigation of their role in transcription
(Bustin) andembryogenesis (Sommerville).
Antibodies specific for different histones
have been obtained by immunizing with
synthetic hexapeptides ofdefined sequence
(Van Regenmortel). Such probes reveal
that the major antigenic sites of histones
are at (H3), or close to (H4) the C-term-
inus, and that these sites are accessible in
nucleosomes and core particles. Changes
in immunofluorescence associated with
two nuclear antigens that are expressed in
GI and G2 but not in S cells were de-
scribed (Turner). One antigen was expres-
sed in metaphase chromosomes and the
other was associated with the nuclear
membrane. Transcription of polytene
chromosomes is being investigated using
monoclonal antibodies against chromoso-
mal proteins (Bautz). One antibody
appears specific for RNA polymerase II,
whilst another selectivelv binds heat-
shock puffs 93D in D. melanoqaster and
48BC in D. hydei, evidently identifying
an hn-RNP class that is stored in the
nucleus. Other antibodies recognize pro-
teins that may link hn-RNA to the
nuclear matrix.
A major potential of antibodies is their
use as histological stains in combination
with a second, labelled antibody, to moni-
tor the distribution and repair of adducts
in cellular subpopulations of target tissues
(Strickland, Zarebska) a method that may
prove quantitative ifcombined with image
intensification and analysis (Rajewsky,
Bustin). However, theaccessibilityofDNA
in situ to antibodies is affected by the
degree of packing in the higher structures
of chromatin or chromosomes (Nehls).
Furthermore the accessibility of adducts
in chromatin in situ is reflected by the
kinetics of excision repair (Slor).
To date, most DNA adducts for which
antibodies are available result from the
reaction of monofunctional agents. Such
antibodies could find immediate applica-
tion in monitoring individual exposure to
specific carcinogens (Legraverend). There
is also considerable interest in the pos-
sibility ofproducing antibodies specific for
DNA-DNA and DNA-protein cross-link-
ages which would be of value in monitor-
ing therapy involving bifunctional agents.
In some disease conditions it may be
useful to measure cell-proliferative status
with antinucleosidc antibodies which react
strongly with cells in S (Bases) or with
antibodies to chromatin proteins expressed
in GJ and G2 (Turner). The ability to
introduce nuclear antibodies into living
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cells by micro-injection (Bustin) or fusion
with loaded erythrocyte ghosts (Slor)
suggests a new means of inhibiting repair
of specific lesions that may help establish
their role in cytotoxicity, mutagenicitv- or
cell transformation.
The Workshop has demonstrated that
this relatively new field of application of
immunological methods to investigate the
structure and modification of chromatin
has great potential in enabling otherwise
impractical studies to be undertaken. As
more and better defined antibodies become
available it is expected that they will
stimulate further ingenuity in elucidating
the molecular architecture of chromatin
and its modification by carcinogenic and
therapeutic agents. W"e look forward to
further exciting future developments.
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